DMPV
Delphi Management Partners VIII Portfolio holdings
AUM
$138M
This Quarter Return
+43.31%
1 Year Return
+56.76%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$127M
AUM Growth
–
Cap. Flow
+$127M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
$59.6M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$43.4M |
| 3 |
CALA
Calithera Biosciences, Inc
CALA
|
$13.9M |
| 4 |
Senseonics Holdings
SENS
|
$9.02M |
| 5 |
MREO
Mereo BioPharma
MREO
|
$842K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 81.95% |
| 2 | Technology | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tandem Diabetes Care
TNDM
$834M
| $59.6M | 47.05% |
+1,000,000
| New | +$59.6M |
|
|
2
Karyopharm Therapeutics
KPTI
$61.4M
| $43.4M | 34.24% |
+2,263,006
| New | +$43.4M |
|
|
CALA
3
DELISTED
Calithera Biosciences, Inc
CALA
| $13.9M | 10.94% |
+2,426,702
| New | +$13.9M |
|
|
4
Senseonics Holdings
SENS
$368M
| $9.02M | 7.12% |
+9,846,294
| New | +$9.02M |
|
|
MREO
5
Mereo BioPharma
MREO
$275M
| $842K | 0.66% |
+256,734
| New | +$842K |
|